Abbott’s life-saving paediatric heart devices, Masters HP 15mm & Amplatzer Piccolo Occluder gets European approval

The Food and Drug Administration (FDA) has granted Fast Track designation to FX-322 (Frequency Therapeutics) for the treatment of sensorineural hearing loss. FX-322 is a combination of proprietary small molecules...

The US FDA has approved Eli Lily’s oral therapy Reyvow (lasmiditan) for the acute treatment of adults with migraine with or without aura, with Lilly noting that this is ‘the first and only FDA-approved medicine in a new...